Table 2 Demographics of the studied patients with perforated peptic ulcer disease Total (n = 47)
Age (years, mean ±SD) | 39.5 ± 8.6 | n= all |
|---|---|---|
Male (%) | 87.2% | n = 41 |
Female (%) | 12.8% | n = 6 |
History of NSAID use (%) | 48.9% | n = 23 1,109 |
Smokers (%) | 66% | n = 31 |
History of ulcer (%) | 29.8% | n = 14 |
ASA I (%) | 10.6% | n = 5 |
ASA II (%) | 76.6% | n = 36 |
ASA III (%) | 10.6% | n = 5 |
ASA IV (%) | 2.1% | n = 1 |
Boey 0 (%) | 14.8% | n = 7 |
Boey 1 (%) | 65.9% | n = 31 |
Boey 2 (%) | 17.2% | n = 8 |
Boey 3 (%) | 2.1% | n = 1 |
Shock at admission (%) | 4.3% | n = 2 |
Duration of symptoms (h) | 11.5 ± 4.3 | n = all |
Free air on X-ray (%) | 85% | n = 40 |
Symptoms >24 h (%) | 8.5% | n = 4 |
Size perforation (mm) | 5.5 ± 3.6 | n = all |
Hospital stay (hours, mean ±SD) | 75 ± 12.6 | n = all |
WBe (mean ±SD) | 12.3 ± 5.6 | n = all |
Localization ulcer | ||
Duodenal (%) | 74.5% | n = 35 |
Juxtapyloric (%) | 6.4% | n = 3 |
Gastric (%) | 19.1% | n = 9 |
WBe white blood cells |